tradingkey.logo

Evotec SE

EVO

3.720USD

+0.030+0.81%
Fechamento 07/22, 16:00ETCotações atrasadas em 15 min
1.32BValor de mercado
PerdaP/L TTM
Mais detalhes de Evotec SE Empresa
Evotec SE is a Germany-based drug discovery and development company. The company is engaged in development of new pharmaceutical products through research alliances and development partnerships with pharmaceutical and biotechnology companies, academic institutions, patient organizations and venture capital companies. The drug discovery solutions are provided in the form of fee-for-service work, integrated drug discovery alliances, development partnerships, licensing of drug candidates and consulting arrangements. Evotec SE operates in a number of areas, including neuroscience, diabetes and complications of diabetes, pain and inflammation, oncology, infectious diseases, respiratory diseases and fibrosis. Its pipeline covers a range of therapeutic areas, such as CNS Insomnia, Chronic cough, immunology & inflammation, women’s health endometriosis, nephrology, dermatological diseases, fibrotic disease and antiviral, among others.
Informações da empresa
Código da empresaEVO
Nome da EmpresaEvotec SE
Data de listagemOct 11, 1999
Fundado em2019
CEODr. Christian Wojczewski
Número de funcionários4827
Tipo de títulosOrdinary Share
Fim do ano fiscalOct 11
EndereçoEssener Bogen 7
CidadeHAMBURG
Bolsa de valoresOMX Nordic Exchange Stockholm AB - cash
PaísGermany
Código postal22419
Telefone4940560810
Sitehttps://www.evotec.com/
Código da empresaEVO
Data de listagemOct 11, 1999
Fundado em2019
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Prof. Dr. Iris Loewfriedrich
Prof. Dr. Iris Loewfriedrich
Independent Chairwoman of the Supervisory Board
Independent Chairwoman of the Supervisory Board
--
--
Mr. Volker Braun
Mr. Volker Braun
Senior Vice President, Head of Global Investor Relations and ESG
Senior Vice President, Head of Global Investor Relations and ESG
--
--
Mr. Wesley Wheeler
Mr. Wesley Wheeler
Member of the Supervisory Board
Member of the Supervisory Board
--
--
Dr. Christian Wojczewski
Dr. Christian Wojczewski
Chief Executive Officer, Member of the Management Board
Chief Executive Officer, Member of the Management Board
--
--
Dr. Duncan Mchale
Dr. Duncan Mchale
Member of the Supervisory Board
Member of the Supervisory Board
--
--
Ms. Camilla Macapili Languille
Ms. Camilla Macapili Languille
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Dr. Constanze Ulmer-Eilfort
Dr. Constanze Ulmer-Eilfort
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Mrs. Aurelie Dalbiez
Mrs. Aurelie Dalbiez
Chief People Officer, Member of the Management Board
Chief People Officer, Member of the Management Board
--
--
Dr. Cord Dohrmann, Ph.D.
Dr. Cord Dohrmann, Ph.D.
Chief Scientific Officer, Member of the Management Board
Chief Scientific Officer, Member of the Management Board
--
--
Ms. Laetitia Rouxel
Ms. Laetitia Rouxel
Chief Financial Officer, Member of the Management Board
Chief Financial Officer, Member of the Management Board
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Prof. Dr. Iris Loewfriedrich
Prof. Dr. Iris Loewfriedrich
Independent Chairwoman of the Supervisory Board
Independent Chairwoman of the Supervisory Board
--
--
Mr. Volker Braun
Mr. Volker Braun
Senior Vice President, Head of Global Investor Relations and ESG
Senior Vice President, Head of Global Investor Relations and ESG
--
--
Mr. Wesley Wheeler
Mr. Wesley Wheeler
Member of the Supervisory Board
Member of the Supervisory Board
--
--
Dr. Christian Wojczewski
Dr. Christian Wojczewski
Chief Executive Officer, Member of the Management Board
Chief Executive Officer, Member of the Management Board
--
--
Dr. Duncan Mchale
Dr. Duncan Mchale
Member of the Supervisory Board
Member of the Supervisory Board
--
--
Ms. Camilla Macapili Languille
Ms. Camilla Macapili Languille
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Detalhamento da receita
Moeda: USDAtualizado em: dom, 6 de jul
Moeda: USDAtualizado em: dom, 6 de jul
FY2024
FY2023
Sem dados
Por RegiãoUSD
Nome
Receita
Proporção
United States
482.23M
55.94%
Switzerland
117.94M
13.68%
United Kingdom
100.06M
11.61%
Rest of the world
89.00M
10.32%
Germany
35.59M
4.13%
Other
37.16M
4.31%
Por Empresa
Por Região
Sem dados
Distribuição de ações
Atualizado em: dom, 13 de jul
Atualizado em: dom, 13 de jul
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Mubadala Investment Company PJSC
1.29%
Wellington Management Company, LLP
0.54%
BlackRock Institutional Trust Company, N.A.
0.42%
DCF Advisers, LLC
0.21%
Morgan Stanley Smith Barney LLC
0.02%
Other
97.52%
Investidores
Investidores
Proporção
Mubadala Investment Company PJSC
1.29%
Wellington Management Company, LLP
0.54%
BlackRock Institutional Trust Company, N.A.
0.42%
DCF Advisers, LLC
0.21%
Morgan Stanley Smith Barney LLC
0.02%
Other
97.52%
Tipos de investidores
Investidores
Proporção
Sovereign Wealth Fund
1.29%
Investment Advisor
0.67%
Investment Advisor/Hedge Fund
0.55%
Hedge Fund
0.02%
Research Firm
0.01%
Other
97.45%
Participação acionária institucional
Atualizado em: ter, 1 de jul
Atualizado em: ter, 1 de jul
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q2
60
9.07M
2.55%
-923.30K
2025Q1
60
9.08M
2.56%
-923.30K
2024Q4
59
8.93M
2.52%
-1.38M
2024Q3
56
8.37M
2.36%
-3.56M
2024Q2
55
7.62M
2.15%
-2.08M
2024Q1
54
5.00M
1.41%
-5.55M
2023Q4
56
5.70M
1.61%
-517.14K
2023Q3
51
1.23M
0.35%
-5.15M
2023Q2
46
1.39M
0.39%
-4.97M
2023Q1
43
1.38M
0.39%
-5.01M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
Mubadala Investment Company PJSC
4.60M
1.29%
--
--
Mar 31, 2025
Wellington Management Company, LLP
1.90M
0.54%
-396.50K
-17.24%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
1.50M
0.42%
+89.47K
+6.34%
Mar 31, 2025
DCF Advisers, LLC
751.58K
0.21%
+521.71K
+226.96%
Mar 31, 2025
Morgan Stanley Smith Barney LLC
63.92K
0.02%
+6.97K
+12.23%
Mar 31, 2025
AllianceBernstein L.P.
47.65K
0.01%
+28.58K
+149.81%
Jun 30, 2024
Tower Research Capital LLC
41.19K
0.01%
+41.19K
--
Mar 31, 2025
Lighthouse Investment Partners, LLC
37.55K
0.01%
-2.26K
-5.67%
Mar 31, 2025
Morgan Stanley & Co. LLC
24.12K
0.01%
-44.85K
-65.03%
Mar 31, 2025
Aperio Group, LLC
21.17K
0.01%
-11.04K
-34.28%
Mar 31, 2025
Ver Mais
ETFs Relacionados
Atualizado em: dom, 6 de jul
Atualizado em: dom, 6 de jul
Nome
Proporção
iShares Biotechnology ETF
0.1%
ActivePassive International Equity ETF
0%
DFA Dimensional Intl Sustainability Core 1 ETF
0%
iShares Biotechnology ETF
Proporção0.1%
ActivePassive International Equity ETF
Proporção0%
DFA Dimensional Intl Sustainability Core 1 ETF
Proporção0%
Dividendo
Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
KeyAI